Shares of Vertex Pharmaceuticals Inc. VRTX shed 4.07% to $448.01 Tuesday, on what proved to be an all-around mixed trading ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

The San Diego biotech made an unsolicited bid to buy Evotec for 2 billion euros. Elsewhere, Bluebird recorded its first ...

A Relative Strength Rating upgrade for Vertex Pharmaceuticals shows improving technical performance. Will it continue?

With promising Phase 1 results in hand, Metsera hopes to develop a longer-lasting GLP-1 injection along with other types of ...

This is to convey that, the Board of Directors of the company have considered and approved Unaudited Financial Statements for the Quarter and Half year ended September 30, 2024.

This is hereby conveyed that, the Board has considered and approved Financial Results for the quarter and Half year ended September 30, 2024.

Futures inched higher while bitcoin topped $80,000 as the Donald Trump rally continues. Nvidia, Meta lead five stocks near buy points.

The experience zone will allow enterprises to witness AI technologies and identify the optimal generative AI use cases.

Explore Claude 3.5 Haiku's strengths, limitations, and market implications in the AI landscape. Uncover the future of AI with ...